科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/08 | 3,985 | 3,990 | 3,910 | 3,935 | +5 | +0.1% | 93,600 |
| 2022/04/07 | 3,890 | 3,945 | 3,870 | 3,930 | +30 | +0.8% | 124,500 |
| 2022/04/06 | 3,945 | 3,955 | 3,885 | 3,900 | -25 | -0.6% | 148,800 |
| 2022/04/05 | 3,975 | 3,975 | 3,915 | 3,925 | ±0 | ±0% | 67,300 |
| 2022/04/04 | 3,955 | 3,955 | 3,920 | 3,925 | +10 | +0.3% | 52,700 |
| 2022/04/01 | 3,890 | 3,935 | 3,870 | 3,915 | +25 | +0.6% | 106,700 |
| 2022/03/31 | 3,935 | 3,945 | 3,880 | 3,890 | -55 | -1.4% | 130,900 |
| 2022/03/30 | 3,945 | 3,965 | 3,900 | 3,945 | -120 | -3% | 181,400 |
| 2022/03/29 | 4,065 | 4,070 | 4,005 | 4,065 | +10 | +0.2% | 88,700 |
| 2022/03/28 | 4,060 | 4,080 | 4,025 | 4,055 | +35 | +0.9% | 82,600 |
| 2022/03/25 | 3,990 | 4,020 | 3,965 | 4,020 | +60 | +1.5% | 136,800 |
| 2022/03/24 | 3,990 | 4,025 | 3,935 | 3,960 | -80 | -2% | 154,800 |
| 2022/03/23 | 3,960 | 4,045 | 3,940 | 4,040 | +100 | +2.5% | 173,900 |
| 2022/03/22 | 3,955 | 3,990 | 3,880 | 3,940 | +5 | +0.1% | 314,000 |
| 2022/03/18 | 4,180 | 4,180 | 3,935 | 3,935 | -260 | -6.2% | 189,700 |
| 2022/03/17 | 4,270 | 4,270 | 4,180 | 4,195 | -5 | -0.1% | 84,700 |
| 2022/03/16 | 4,135 | 4,235 | 4,130 | 4,200 | +65 | +1.6% | 97,100 |
| 2022/03/15 | 4,075 | 4,150 | 4,070 | 4,135 | +85 | +2.1% | 59,500 |
| 2022/03/14 | 4,135 | 4,145 | 4,035 | 4,050 | -85 | -2.1% | 67,600 |
| 2022/03/11 | 4,160 | 4,185 | 4,135 | 4,135 | -75 | -1.8% | 60,900 |
| 2022/03/10 | 4,190 | 4,220 | 4,160 | 4,210 | +75 | +1.8% | 109,600 |
| 2022/03/09 | 4,100 | 4,145 | 4,100 | 4,135 | +5 | +0.1% | 77,600 |
| 2022/03/08 | 4,125 | 4,155 | 4,110 | 4,130 | +10 | +0.2% | 103,400 |
| 2022/03/07 | 4,110 | 4,125 | 4,085 | 4,120 | +5 | +0.1% | 68,200 |
| 2022/03/04 | 4,130 | 4,180 | 4,115 | 4,115 | -50 | -1.2% | 53,800 |
| 2022/03/03 | 4,105 | 4,195 | 4,105 | 4,165 | +70 | +1.7% | 75,300 |
| 2022/03/02 | 4,130 | 4,155 | 4,090 | 4,095 | -105 | -2.5% | 122,400 |
| 2022/03/01 | 4,240 | 4,250 | 4,195 | 4,200 | -20 | -0.5% | 51,500 |
| 2022/02/28 | 4,135 | 4,230 | 4,135 | 4,220 | +115 | +2.8% | 55,000 |
| 2022/02/25 | 4,165 | 4,190 | 4,085 | 4,105 | -45 | -1.1% | 38,500 |
| 2022/02/24 | 4,100 | 4,160 | 4,080 | 4,150 | +30 | +0.7% | 45,000 |
| 2022/02/22 | 4,120 | 4,140 | 4,105 | 4,120 | -20 | -0.5% | 55,200 |
| 2022/02/21 | 4,160 | 4,165 | 4,120 | 4,140 | -75 | -1.8% | 44,800 |
| 2022/02/18 | 4,215 | 4,240 | 4,180 | 4,215 | +10 | +0.2% | 36,300 |
| 2022/02/17 | 4,300 | 4,305 | 4,200 | 4,205 | -100 | -2.3% | 46,600 |
| 2022/02/16 | 4,305 | 4,320 | 4,280 | 4,305 | +65 | +1.5% | 66,000 |
| 2022/02/15 | 4,250 | 4,275 | 4,220 | 4,240 | +5 | +0.1% | 51,100 |
| 2022/02/14 | 4,180 | 4,240 | 4,140 | 4,235 | +40 | +1% | 72,800 |
| 2022/02/10 | 4,160 | 4,205 | 4,160 | 4,195 | +35 | +0.8% | 98,200 |
| 2022/02/09 | 4,160 | 4,170 | 4,140 | 4,160 | +20 | +0.5% | 59,300 |
| 2022/02/08 | 4,125 | 4,170 | 4,125 | 4,140 | +35 | +0.9% | 59,000 |
| 2022/02/07 | 4,070 | 4,130 | 4,070 | 4,105 | +10 | +0.2% | 64,300 |
| 2022/02/04 | 4,105 | 4,115 | 4,050 | 4,095 | -95 | -2.3% | 91,900 |
| 2022/02/03 | 4,200 | 4,225 | 4,180 | 4,190 | -10 | -0.2% | 58,300 |
| 2022/02/02 | 4,150 | 4,210 | 4,140 | 4,200 | +55 | +1.3% | 52,100 |
| 2022/02/01 | 4,100 | 4,175 | 4,095 | 4,145 | +45 | +1.1% | 57,000 |
| 2022/01/31 | 4,180 | 4,180 | 4,085 | 4,100 | -105 | -2.5% | 92,100 |
| 2022/01/28 | 4,210 | 4,230 | 4,185 | 4,205 | +60 | +1.4% | 61,300 |
| 2022/01/27 | 4,195 | 4,215 | 4,125 | 4,145 | -25 | -0.6% | 88,100 |
| 2022/01/26 | 4,240 | 4,240 | 4,160 | 4,170 | -55 | -1.3% | 53,800 |
751～
800
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
